NASDAQ:SOLY

Soliton (SOLY) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$22.58
$22.58
50-Day Range
$20.10
$22.58
52-Week Range
$7.40
$22.60
Volume
N/A
Average Volume
347,827 shs
Market Capitalization
$487.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SOLY stock logo

About Soliton Stock (NASDAQ:SOLY)

Soliton, Inc. is a medical development company, which engages in the development of healthcare technological devices for medical and cosmetic treatments. Its technology platform include Rapid Acoustic Pulse, a device uses rapid pulses of designed acoustic shockwaves to disrupt cellular structures in the dermal and subdermal tissue. The firm is also in the pre-revenue stage with its first products being developed for the removal of tattoos and the reduction of cellulite. The company was founded by Walter V. Klemp and Christopher Capelli on March 27, 2012 and is headquartered in Houston, TX.

SOLY Stock News Headlines

Mysterious Gold Leverage Just Announced
World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.
General Maximum - Seeking Alpha
Mysterious Gold Leverage Just Announced
World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.
Allergan Aesthetics Completes Acquisition of Soliton
See More Headlines
Receive SOLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Soliton and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/12/2021
Today
4/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:SOLY
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

Net Income
$-14,540,000.00
Pretax Margin
-4,831.89%

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.46 per share

Miscellaneous

Free Float
19,005,000
Market Cap
$487.66 million
Optionable
Not Optionable
Beta
0.19
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Bradley A. Hauser
    President, Chief Executive Officer & Director
  • Joseph D. Tanner
    Chief Operating Officer
  • Lori Bisson
    Chief Financial Officer, Secretary & Executive VP
  • Christopher Capelli
    Vice Chairman & Chief Science Officer
  • Mary Stoll
    Senior Director-Clinical Development

SOLY Stock Analysis - Frequently Asked Questions

How were Soliton's earnings last quarter?

Soliton, Inc. (NASDAQ:SOLY) issued its quarterly earnings data on Thursday, August, 12th. The company reported ($0.37) EPS for the quarter, missing the consensus estimate of ($0.30) by $0.07.

What other stocks do shareholders of Soliton own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Soliton investors own include Cronos Group (CRON), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), AbbVie (ABBV), Micron Technology (MU), Block (SQ) and Verizon Communications (VZ).

This page (NASDAQ:SOLY) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners